XIAP and breast carcinoma: Interestingly, Lee et al. confirmed that syringin inhibited the growth of breast carcinoma cells by up-regulation p21, cleaved caspase-3/caspase-9 and PARP, and down-regulation CDK4 and XIAP [14].